Return to the catalog
Semax
NewIn Stock10mg vial

Semax

ACTH-derived peptide studied for brain-cell support, learning, and stress response.

For Research Use Only

Sold strictly for laboratory research. Not for human or veterinary use, ingestion, or clinical/diagnostic application.

1–4 vialsR 650.00
5+ vials — save 20%R 520.00 each

The lower price is applied automatically once your cart holds 5 or more of this vial.

Bacteriostatic water included

99%+ Purity
Extensively Researched
1

About this peptide

Semax is a synthetic peptide derived from a fragment of the natural hormone ACTH. It is widely investigated for its neuroprotective and cognitive effects, particularly its ability to upregulate key brain neurotrophic factors like BDNF and NGF that help nerve cells survive, adapt, and form new connections. In research protocols, scientists explore Semax for its potential to support sharpened focus, memory retention, healthy cerebral blood flow, and resistance to mental fatigue.

Why researchers reach for Semax

BDNF upregulation

Referenced across rodent hippocampal expression studies.

Neuroprotective models

Explored in ischemia and cognitive stress paradigms.

Melanocortin lineage

Non-hormonal ACTH(4-10) fragment analogue.

Key features

  • ≥99% HPLC purity
  • ACTH(4-10) heptapeptide analogue
  • Mass-spec verified
  • Cold-chain dispatch

How it works

Neurotrophin induction

Increases BDNF and NGF expression in vitro.

Monoamine modulation

Alters dopamine and serotonin turnover in rodent brain.

Enkephalin activity

Inhibits enkephalin degradation, extending endogenous signaling.

Research dosage guidelines

Reference ranges only — reproduced from published preclinical literature. Not a recommendation for human use.

RangeReported doseNote
Typical reconstitution2 mL bacteriostatic waterYields 5 mg/mL (5000 mcg/mL)
Reported research range200–600 mcg/dayReference only

Tracking this compound? Registered researchers can log active Semax protocols in their private Research Log.

Timing in research protocols

Intranasal, split across the day, in defined courses rather than continuously.

  • The most cited clinical work (Gusev and Martynov, 2018, post-stroke) used 6,000 mcg per day intranasally in two 10-day courses separated by a 20-day interval.
  • Daytime split dosing reflects rapid intranasal absorption and a short duration of action.
  • The 10-days-on, several-weeks-off course structure recurs throughout the Russian nootropic-peptide literature.
  • No meal relationship is reported in the primary studies.

Drawn from published research protocols and pharmacology literature. Reference information for laboratory research only — not an instruction or guidance for use.

Technical specifications

Sequence
Met-Glu-His-Phe-Pro-Gly-Pro
Molecular weight
813.9 g/mol
Purity
≥99% (HPLC)
Form
Lyophilized powder
Vial size
10 mg
Storage (lyophilised vial)
Cool, dry and protected from light
Storage (after reconstitution)
2–8°C

Published research

Peer-reviewed literature on Semax. Links open in a new tab.

Research use notice

Sold for in vitro laboratory research only. Not for human or veterinary use, diagnosis, or therapy.

#nootropic#BDNF#neurotrophic

Cart (0)

Your cart is empty